Skip to main content

Table 1 % of TSGs upregulated by promoter hypomethylation and % of Oncogenes downregulated by promoter hypermethylation after each treatment

From: Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09

 

ST08

ST09

TSGs(% Upregulation)

11

9

Oncogenes(% downregulation)

16

12

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us